08.01.2015 Views

1 Selective serotonin reuptake inhibitors (SSRI) – sales, withdrawal ...

1 Selective serotonin reuptake inhibitors (SSRI) – sales, withdrawal ...

1 Selective serotonin reuptake inhibitors (SSRI) – sales, withdrawal ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Results<br />

We identified 6 documents related to the benzodiazepines and 23 documents for the <strong>SSRI</strong>s (table 2).<br />

All documents are official ones and convey drug regulators’ and other health authorities' positions,<br />

i.e. they express one-way communication and are authoritative. A public and media focus on the<br />

<strong>SSRI</strong> <strong>withdrawal</strong> syndrome initiated a review process, during which working groups were<br />

established in drug agencies that referred to each other in the documents. References are shown in<br />

table 2.<br />

Time to recognise adverse effects<br />

Two papers from the Committee on Safety of Medicines (UK) from 1980 and 1988, an article from<br />

the Committee in 1993, and minutes from the Committee in 2004 (see table 2) showed that it took<br />

more than eight years for the UK regulators to accept the frequency and seriousness of the<br />

dependence potential of benzodiazepines, and ten years to accept <strong>withdrawal</strong> reactions as a class<br />

effect of <strong>SSRI</strong>s and that the symptoms can be serious.<br />

In both cases, the source of the assessments was the spontaneous reporting system for adverse drug<br />

reactions, as shown in a systematic review by the Committee on the Review of Medicines (1980)<br />

and an article by Price et al. (1996).<br />

Increasing frequency and seriousness of dependence and <strong>withdrawal</strong> reactions<br />

The frequency and seriousness of the reactions related to benzodiazepines increased in the<br />

assessments over time. In 1980, the estimate of people suffering from benzodiazepine dependence<br />

was low, only 28 persons in the UK (Committee on the Review of Medicines, 1980), but in 1988,<br />

the risk of dependence was becoming “increasingly worrying” (Medicines Control Agency). From<br />

1980, restricted use of benzodiazepines was recommended from 1980 (Committee on the Review of<br />

Medicines, 1980), i.e. short-term use, doses within the therapeutic range and gradual <strong>withdrawal</strong>.<br />

From the meeting minutes in the UK Medical Research Council, an estimate of the frequency of<br />

dependence appears low, but because many people used benzodiazepines, the number of dependent<br />

people was assessed to be around 10,000 – 100,000 people in UK (Medical Research Council<br />

Headquarters file 1980-82).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!